News & Events

• November 30, 2022
  

  eCOA Consortium Announces New Article for Applied Clinical Trials

  C-Path’s eCOA Consortium is pleased to announce that “Implementing Numeric Rating and Visual Analog Scales in an eCOA Solution” has been published in Applied Clinical Trials. The article serves as a primer on the implementation of the NRS and VAS on eCOA systems and includes tips for ensuring eCOA implementations adhere to best practice recommendations. Access here:  https://www.appliedclinicaltrialsonline.com/view/implementing-numeric-rating-and-visual-analog-scales-in-an-ecoa-solution
• November 3, 2022
  

  eCOA Consortium Announces New Article for Applied Clinical Trials

  C-Path’s eCOA Consortium is pleased to announce that “Survey Investigates Backup Solution Adoption for ePRO Systems” has been published in Applied Clinical Trials. The article, the second in a two-part series, presents results from a survey that investigates backup solution adoption, justifications for solution selection, reasons why paper persists, and how backup data are evaluated....
• September 29, 2022
  

  eCOA Consortium Announces New Article for Applied Clinical Trials

  C-Path’s eCOA Consortium is pleased to announce that “Evaluating the Use of Backup Solutions for ePRO Systems” has been published in Applied Clinical Trials.

• September 27, 2022
  

  Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation

  C-Path today named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer (CEO). An experienced leader in drug development, healthcare and business, Jorgensen will continue C-Path’s distinguished reputation of collaboration with global stakeholders, including patient groups, academic institutions, the pharmaceutical industry and regulatory agencies, to set a vision for C-Path’s next phase of growth and innovation. Jorgensen’s tenure as CEO will commence on the first of October.

• September 8, 2022
  

  C-Path’s Kristen Swingle Named President

  Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-Path) today announced that its Chief Operating Officer (COO) and Interim President, Kristen Swingle, M.S., has been named COO and President, effective immediately. Swingle has filled the interim President role since 2021, stewarding C-Path...